Vega LCA, Ariza AR

Language: Spanish
References: 24
Page: 217-223
PDF size: 240.86 Kb.

ABSTRACT

Bartonella spp. is a gram-negative microorganism that can produce several illnesses. They have a wide geographical distribution and transmission mechanisms. It has recently been shown that can induce vascular proliferation and has been recognized as the etiological agent of bacillary angiomatosis and hepatic peliosis. In this article we review the general aspects of infections due to Bartonella spp, its epidemiology, its major clinical manifestations, as well as their treatment and prevention. It is important to consider Bartonella spp and better know its epidemiology, to reduce its morbidity and mortality.

REFERENCES

1. Blanco JR, Raoult D. Enfermedades producidas por Bartonella spp. Enferm Infecc Microbiol Clin 2005;23(5):313-20.

2. Chomel B, Boulois H, Muruyama S, Breitschwerdt E. Bartonella spp. in pets and effect on human health. Emerg Infect Dis 2006;12:389-94.

3. Eremeeva M, Gerns HL, Lydy SL, Goo JS, et al. Bacteremia, fever, and splenomegaly caused by a newly recognized bartonella species. N Engl J Med 2007;356:2381-7.

4. Maguina C, García P, Gotuzzo E, Cordero L, et al. Bartonellosis (Carrion disease) in the modern era. Clin Infect Dis 2001;33:772-9.

5. Vinson JW. In vitro cultivation of the rickettsial agent of trench fever. Bull Wld Health Org 1966;35:155-64.

6. Manfredi R, Sabbatani S, Chiodo F. Bartonellosis: light and shadows in diagnostic and therapeutic issues. Clin Microbiol Infect 2005;11(3):167-9.

7. Ohl ME, Spach DH. Bartonella quintana and urban trench fever. Clin Infect Dis 2000;31:131-5.

8. NTS No. 048 -MINSA/DGSP- V.01. Norma técnica de salud para la atención de la bartonelosis o enfermedad de Carrión en el Perú 2006. Dirección URL: .

9. Kirby JE, Nekorchuk DM. Bartonella-associated endothelial proliferation depends on inhibition of apoptosis. Proc Natl Academ Sci USA 2002;99(7):4656-61.

10. Arvand M, Wendt C, Regnath T. Characterization of Bartonella henselae Isolated from bacillary angiomatosis lesions in a human immunodeficiency virus-infected patient in Germany. Clin Infect Dis 1998;26:1296-9.

11. Schutze GE. Diagnosis and treatment of Bartonella henselae infections. Pediatr Infect Dis J 2000;16:1185-8.

12. Ferres M, Abarca K, Godoy P, García P y col. Presencia de Bartonella henselae en gatos: cuantificación del reservorio natural y riesgo de exposición humana de esta zoonosis en chile. Rev Med Chile 2005;133:1465-71.

13. Rolain JM, Locatelli C, Chabanne L, Davoust B, Raoult D. Prevalence of Bartonella clarridgeae and Bartonella henselae in domestic cats form France and detection of the organisms in erythrocytes by immunofluorescence. Clin Diagn Lab Immunol 2004;11(2):423-25.

14. Vásquez P, Chanqueo L, García P, Poggi H y col. Angiomatosis bacilar por Bartonella quintana en un paciente con infección por virus de inmunodeficiencia humana. Rev Chil Infect 2007;24(2):155-9.

15. Cockerell CJ, LeBoit PE. Bacillary angiomatosis: a newly characterized, pseudoneoplastic, infectious, cutaneous vascular disorder. J Am Acad Dermatol 1990;22:501-12.

16. Wormser G. Discovery of new infectious diseases - Bartonella epecies. N Engl J Med 2007;356;23:2346-7.

17. Seki N, Sasaki T, Sawabe K, Sasaki T, et al. Epidemiological studies on Bartonella quintana infections among homeless people in Tokyo, Japan. Jpn J Infect Dis 2006;59:31-35.

18. Koehler JE, Sanchez MA, Tye S, Garrido-Rowland CS, et al. Prevalence of Bartonella infection among human immunodeficiency virus-infected patients with fever. Clin Infect Dis 2003;37:559-66.

19. Cilla G, Montes M, López D, Iraola B, Aramburu B. Endocarditis por Bartonella henselae: presentación de un caso y revisión de la literatura. An Med Interna (Madrid) 2001;18:255-8.

20. Brenner S, Rooney J, Manzewitsch P, Regnery R. Isolation of Bartonella henselae: effects of methods of blood collection and handling. J Clin Microbiol 1997;35(3):544-7.

21. Rolain JM, Brouqui P, Koehler JE, Maguina C, et al. Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother 2004;48(6):1921-33.

22. Bass JW, Freitas BC, Freitas AD, Sisler CL, et al. Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease. Pediatr Infect Dis J 1998;17:447-52.

23. Tarazona A, Maguiña C, López D, Montoya M y col. Terapia antibiótica para el manejo de la bartonelosis o enfermedad de Carrión en el Perú. Rev Perú Med Exp Salud Pública 2006;23(3).

24. Grant S, Olsen CW. Preventing zoonotic diseases in immunocompromised persons: the role of physicians and veterinarians. Emerg Infect Dis 1999;5(1):159-63.